SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,867.48 179.64
(0.35%)

Dow Jones

7,378.60 -7.86
(-0.11%)

Hang Seng

72,467.78 3,292.81
(4.76%)

Nikkei 225

10,453.87 25.02
(0.24%)

Forex

USD-INR

94.74 0.21
(0.22%)

EUR-INR

108.00 -0.19
(-0.17%)

GBP-INR

125.20 0.11
(0.09%)

JPY-INR

0.59 0.00
(0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

43.18

40650.3

EPS(TTM)

Face Value()

Div & Yield %

75.36

0.86

Back

piramal capital & housing finance ltd

Riddhi Corporate Services standalone net profit declines 64.52% in the December 2025 quarter

Feb 15,2026

Net profit of Riddhi Corporate Services declined 64.52% to Rs 2.86 crore in the quarter ended December 2025 as against Rs 8.06 crore during the previous quarter ended December 2024. Sales rose 126.64% to Rs 135.26 crore in the quarter ended December 2025 as against Rs 59.68 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	135.26	59.68	127
OPM %	4.50	10.82	-
PBDT	6.27	11.78	-47
PBT	3.94	7.27	-46
NP	2.86	8.06	-65

77,100.47 109.25 ( 0.14%)

51,867.48 179.64 (0.35%)

7,378.60 -7.86 (-0.11%)

72,467.78 3,292.81 (4.76%)

10,453.87 25.02 (0.24%)

94.74 0.21 (0.22%)

108.00 -0.19 (-0.17%)

125.20 0.11 (0.09%)

0.59 0.00 (0.26%)